TCIM
CNCE
TIAA CREF Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.35M | Buy |
112,204
+5,300
| +5% | +$64K | ﹤0.01% | 2181 |
|
|
2018
Q4 | $1.34M | Sell |
106,904
-28,695
| -21% | -$360K | ﹤0.01% | 2165 |
|
|
2018
Q3 | $2.01M | Sell |
135,599
-41,500
| -23% | -$616K | ﹤0.01% | 2117 |
|
|
2018
Q2 | $2.98M | Buy |
177,099
+35,787
| +25% | +$602K | ﹤0.01% | 1958 |
|
|
2018
Q1 | $3.24M | Sell |
141,312
-32,145
| -19% | -$736K | ﹤0.01% | 1836 |
|
|
2017
Q4 | $4.49M | Buy |
173,457
+62,343
| +56% | +$1.61M | ﹤0.01% | 1673 |
|
|
2017
Q3 | $1.64M | Sell |
111,114
-18,705
| -14% | -$276K | ﹤0.01% | 2277 |
|
|
2017
Q2 | $1.81M | Buy |
129,819
+4,636
| +4% | +$64.7K | ﹤0.01% | 2236 |
|
|
2017
Q1 | $2.14M | Buy |
125,183
+19,078
| +18% | +$326K | ﹤0.01% | 2106 |
|
|
2016
Q4 | $1.09M | Buy |
106,105
+1,558
| +1% | +$16K | ﹤0.01% | 2486 |
|
|
2016
Q3 | $1.06K | Sell |
104,547
-1,859
| -2% | -$19 | ﹤0.01% | 2512 |
|
|
2016
Q2 | $1.2M | Buy |
106,406
+1,390
| +1% | +$15.6K | ﹤0.01% | 2418 |
|
|
2016
Q1 | $1.44M | Buy |
105,016
+1,846
| +2% | +$25.2K | ﹤0.01% | 2269 |
|
|
2015
Q4 | $1.96M | Buy |
103,170
+21,900
| +27% | +$415K | ﹤0.01% | 2170 |
|
|
2015
Q3 | $1.53M | Buy |
81,270
+65,177
| +405% | +$1.22M | ﹤0.01% | 2309 |
|
|
2015
Q2 | $240K | Buy |
+16,093
| New | +$240K | ﹤0.01% | 3100 |
|
|
2014
Q4 | – | Sell |
-3,196
| Closed | -$40K | – | 3156 |
|
|
2014
Q3 | $40K | Sell |
3,196
-30,500
| -91% | -$382K | ﹤0.01% | 3118 |
|
|
2014
Q2 | $340K | Buy |
33,696
+8,332
| +33% | +$84.1K | ﹤0.01% | 3059 |
|
|
2014
Q1 | $341K | Buy |
+25,364
| New | +$341K | ﹤0.01% | 3029 |
|